Skip to main content
OpenTrials

Clinical trial condition

Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG

Explore clinical trials studying Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG trial results

Recruiting

Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients

NCT03945162

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +14 more
Locations
  • Site 02-012 - University of Chicago Chicago, Illinois, United States
  • Site 02-016 - Urology of Indiana Greenwood, Indiana, United States
  • Site 02-015 - Associated Medical Professionals of New York Syracuse, New York, United States
  • Site 02-017 - Central Ohio Urology Group Gahanna, Ohio, United States
View all 16 locations
View Trial Details

Related conditions